Jose A. Gonzalez-Nakauma
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Transcriptomic profiling across stages of non-muscle-invasive bladder cancer identifies fibroblast activation protein-alpha as a stromal biomarker associated with progression.
Journal: Molecular medicine (Cambridge, Mass.)
Published: February 06, 2026
Proceedings of the first international NMIBC consensus classification meeting.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: December 15, 2025
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort Analysis.
Journal: European urology oncology
Published: December 19, 2024
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.
Journal: Molecular oncology
Published: July 25, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 24, 2024
Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature.
Journal: Cell genomics
Published: September 15, 2023
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
Journal: Nature communications
Published: June 17, 2022
Reply to Yuxuan Song, Caipeng Qin, and Tao Xu's Letter to the Editor re: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6.
Journal: European urology
Published: May 18, 2022
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
Journal: Molecular oncology
Published: October 04, 2021
Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 02, 2020
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
Journal: International journal of cancer
Published: August 06, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026